Molecule Details
| InChIKey | QMMMGQKKOKYDMN-UHFFFAOYSA-N |
|---|---|
| Compound Name | Lauroguadine |
| Canonical SMILES | CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 5 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.16 |
| Source | ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB20829 |
|---|---|
| Drug Name | Lauroguadine |
| CAS Number | 135-43-3 |
| Groups | experimental |
| ATC Codes | nan |
| Description | Lauroguadine is a small molecule drug. Lauroguadine has a monoisotopic molecular weight of 376.3 Da. |
Cross-references: ChEBI: 135583 CHEMBL1980715 ZINC: ZINC000008214597
Target Activities (5)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| O43293 | DAPK3 | Homo sapiens | Human | PF00069 | 6.5 | Ki | ChEMBL |
| Q05655 | PRKCD | Homo sapiens | Human | PF00130 PF21494 PF00069 PF00433 | 6.2 | Ki | ChEMBL |
| P52333 | JAK3 | Homo sapiens | Human | PF18379 PF18377 PF17887 PF07714 PF21990 | 6.1 | Ki | ChEMBL |
| O60674 | JAK2 | Homo sapiens | Human | PF18379 PF18377 PF17887 PF07714 PF21990 | 6.0 | Ki | ChEMBL |
| P51451 | BLK | Homo sapiens | Human | PF07714 PF00017 PF00018 | 6.0 | Ki | ChEMBL |